Evidence map›Paper›PMID 39216201›Full record

ArticleDrug and alcohol dependence2024

Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021.

George Karandinos, Jay Unick, Jeff Ondocsin, Nicole Holm, Sarah Mars, Fernando Montero, Daniel Rosenblum, Daniel Ciccarone

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Donovan Memorial Lecture: 'Fentanyl-Plus': A New Era of Fentanyl Polydrug Combinations in the North American Overdose Crisis.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Early evidence of the effects of xylazine-adulterated fentanyl in Ohio.The International journal on drug policy · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

George KarandinosDivision of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA 02114, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: gkarandinos@mgh.harvard.edu.
Jay UnickUniversity of Maryland, School of Social Work, 525 W Redwood St, Baltimore, MD 20201, USA. Electronic address: junick@ssw.umaryland.edu.
Jeff OndocsinFamily and Community Medicine, University of California San Francisco, 490 Illinois Street, Box 0900, San Francisco, CA 94158, USA. Electronic address: jeffrey.ondocsin@ucsf.edu.
Nicole HolmFamily and Community Medicine, University of California San Francisco, 490 Illinois Street, Box 0900, San Francisco, CA 94158, USA. Electronic address: nicole.holm@ucsf.edu.
Sarah MarsFamily and Community Medicine, University of California San Francisco, 490 Illinois Street, Box 0900, San Francisco, CA 94158, USA. Electronic address: sarah.mars@ucsf.edu.
Fernando MonteroHIV Center for Clinical and Behavioral Studies and Social Intervention Group (SIG), Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Daniel RosenblumDepartment of Economics, Dalhousie University, 6214 University Avenue, Halifax, NS B3H 4R2, Canada. Electronic address: daniel.rosenblum@dal.ca.
Daniel CiccaroneFamily and Community Medicine, University of California San Francisco, 490 Illinois Street, Box 0900, San Francisco, CA 94158, USA. Electronic address: daniel.ciccarone@ucsf.edu.

Funding

Synthetics in Combination (SYNC)R01DA054190 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL H CICCARONE · 2021 to 2026
$4.3M
NIDA NIH HHS R01 DA054190
6 · The paper itself

Abstract

backgroundInjecting, smoking, and snorting heroin/synthetic opioids is each associated with unique health risks. It is unclear how route of administration (ROA) preferences have shifted during the opioid epidemic.

methodsUsing 2000-2021 admissions data from SAMHSA TEDS-A, we analyzed trends in heroin/synthetic opioid ROA preferences and factors associated with these preferences.

results7,881,318 heroin/synthetic opioid admissions reported injection, smoking, or snorting preference. Nationally, injection peaked in 2014 (69.9 %) and nadired in 2021(52.2 %), snorting nadired in 2014 (24.9 %) and peaked in 2021 (36.4 %), and smoking rose steadily from 2.5 % in 2005 to a peak of 11.4 % in 2021. From 2000-2021, the number of states with ≥10 % smoking rates grew from 2 to 27 (highest: 57.0 % in Arizona in 2021). In 2021, increased adjusted prevalence ratios (APR) of non-injection versus injection use were associated with older age at first opioid use (APR 1.52 [95 % CI: 1.51, 1.54] for those 30+ relative to ≤20), and all race/ethnicities relative to non-Latino White individuals (highest: Black individuals, APR 1.77 [1.75, 1.78]). Geography strongly predicted smoking versus snorting (Mountain APR 6.91 [6.64, 7.19], Pacific APR 6.61 [6.35, 6.88], reference: New England).

conclusionsROA preferences of heroin/synthetic opioids have changed substantially since 2000, with: 1) recent decreases in injection nationally; 2) increased smoking, particularly in the western US; and, 3) recent increased snorting in the eastern US. Smoking is now prevalent and growing. Public health implications include an increasing number of smoking-related fatal overdoses and the probable reduction of injection-specific morbidity and increase in smoking-specific morbidity.

Indexed as

HeroinOpioid-Related DisordersAdolescentAdultAnalgesics, OpioidFemaleHumansMaleMiddle AgedSmokingSubstance Abuse, IntravenousSynthetic DrugsUnited StatesYoung AdultAnalgesics, OpioidHeroinSynthetic DrugsOpioid epidemicOpioid injectingOpioid smokingOpioid use disorder (OUD)People who use drugsRoute of administration preferences

Identifiers

PMID39216201
PMCPMC11684856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.